Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia

摘要

The aim of this study to impact of blood count recovery based complete remission before allogeneic hematopoietic stem cell transplantation (alloHSCT) on survival in patients with acute myeloid leukemia. We observed an equivalent post-transplant outcome between patients who were in complete remission and patients who were in complete response with incomplete blood count recovery before alloHSCT. We assume that alloHSCT eliminated the negative effect of pretransplant blood count levels.